Company Analysis

LifeMD, Inc. (LFMD)

Nasdaq: LFMD · Services-Offices & Clinics of Doctors of Medicine · New York, NY · filing with the SEC since 2012
Grade6.4
◀ Past 5.3● Present 7.1▶ Future 6.4
The companyfiscal 2025, as filed
Revenue$194M+25.3%
Net income$14.4M+167.0%
Earnings per share$0.25+141.7%
Operating cash flow$8.3M-52.7%
Cash$36.8M+12.7%
Debtn/a
Shareholders’ equity$23.2M+354.9%
Shares, diluted45.1M+9.5%
Return on equity62.0%
The recordfrom its filings
Filings in 202634
Newest filingNov 12 · 10-Q
Annual reportMar 10, 2026
Quarterly reportNov 12, 2026
Next report due10-K by Mar 16
Insider sales, 12 months$100,000
Insider buys, 12 months$0.00
Patents granted7
Filer categoryAccelerated filer
Trailing twelve months to Sep 2026Revenue $189MNet income $400,420Cash from operations -$10.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 12, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Sep 15, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 13, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton LFMD · research, not advice